NASDAQ · Medical - Diagnostics & Research

Akumin Inc. (AKU) Stock

$0.29 -17.87% NASDAQ: AKU Healthcare

Akumin Inc. specializes in delivering outpatient diagnostic imaging solutions across the United States.

Valuation

MetricValue
Price$0.29
Market Cap$26.27M
P/E Ratio-0.17
P/B Ratio-0.54
P/S Ratio0.04
EPS (TTM)$-1.69
52-Week High$1.90
52-Week Low$0.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-531.99%
ROA-8.59%
ROCE2.61%
Gross Margin18.84%
Operating Margin5.56%
Net Margin-20.22%
Debt/Equity-30.70
Current Ratio1.14

Annual Financials (USD)

Metric20182019202020212022
Revenue$155.0M$247.0M$251.0M$421.0M$750.0M
Operating Profit$16.0M$46.0M$21.0M$13.0M$42.0M
Net Profit$8.0M$9.0M$-18.0M$-35.0M$-152.0M
EPS$0.13$0.13$-0.25$-0.45$-1.69
Op Margin10.1%18.5%8.3%3.1%5.6%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$241.0M$663.0M$719.0M$1.9B$1.8B
Total Liabilities$134.0M$522.0M$579.0M$1.6B$1.6B
Cash$19.0M$23.0M$44.0M$48.0M$59.0M
Borrowings$118.0M$478.0M$538.0M$1.4B$1.5B

Latest News

OP Pohjola's President and Group CEO Timo Ritakallio has announced that he will retire on 1 July 2027 as specified in his executive contract GlobeNewswire · Jul 23, 2026 Tocvan Discovers New High-Grade At-Surface Silver-Gold Zone 900 m East of Pilot Facility at Gran Pilar Project ACCESS Newswire · Jul 23, 2026 Constellation Brands Shareholders Approve Directors, Pay and Incentive Plan at Annual Meeting MarketBeat · Jul 23, 2026 Eco (Atlantic) Oil and Gas Ltd Announces Audited Results for the Year Ended 31 March 2026 ACCESS Newswire · Jul 23, 2026 OP Corporate Bank plc's Half-year Financial Report 1 January–30 June 2026 GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$6.0M$20.0M$27.0M$17.0M$65.0M
Investing Cash Flow$-73.0M$-244.0M$-31.0M$-797.0M$-83.0M
Financing Cash Flow$64.0M$215.0M$11.0M$766.0M$-16.0M
Net Cash Flow$7.0M$4.0M$21.0M$4.0M$11.0M
Free Cash Flow$-3.0M$7.0M$13.0M$-1.0M$21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA10.34
FCF Yield78.43%
Quick Ratio1.09
Interest Coverage0.35
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABDXFAbingdon Health Plc $0.13 +1.21% -11.61 $25.13M 0.00%
AWHAspira Women's Health Inc. $0.08 -15.90% -0.32 $2.46M 0.00%
CNTGCentogene N.V. $0.33 +100.00% -0.22 $9.42M 0.00%
DMTKQDermTech, Inc. $0.00 0.00 $3496 0.00%
LMDXLumiraDx Limited $0.02 +0.00% -0.01 $5.10M 0.00%

About Akumin Inc.

Akumin Inc. specializes in delivering outpatient diagnostic imaging solutions across the United States. Its operations are divided into two main divisions: Radiology and Oncology. Through a network of roughly 200 imaging centers, which it either owns or manages, Akumin delivers a wide array of medical imaging modalities. These include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and various other diagnostic or interventional radiology procedures. The company extends its outpatient radiology and oncology services and comprehensive solutions to approximately 1,000 hospitals and healthcare systems spanning 46 states. Established in 2015, Akumin Inc. maintains its corporate headquarters in Plantation, Florida.

Akumin Inc. is headquartered in US.

Akumin Inc. (AKU) stock trades at $0.29 with a market capitalization of $26.27M. The stock is valued at a price-to-earnings (P/E) ratio of -0.17, price-to-book of -0.54, price-to-sales of 0.04. Over the past 52 weeks the stock has ranged between $0.12 and $1.90, and currently trades 84.7% below its 52-week high.

On profitability, Akumin Inc. generates a return on equity (ROE) of -531.99%, return on capital employed of 2.61%, an operating margin of 5.56%, a net profit margin of -20.22%.

Official website: www.akumin.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides